Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke
The objective of this study was to characterize the pharmacokinetics of gavestinel in patients with acute stroke. Gavestinel was administered as an 800-mg loading dose and followed by either 100-, 200-, or 400-mg maintenance doses given every 12 h for five doses. Blood and urine samples were collect...
Gespeichert in:
Veröffentlicht in: | European journal of clinical pharmacology 2000-02, Vol.55 (11-12), p.867-872 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The objective of this study was to characterize the pharmacokinetics of gavestinel in patients with acute stroke.
Gavestinel was administered as an 800-mg loading dose and followed by either 100-, 200-, or 400-mg maintenance doses given every 12 h for five doses. Blood and urine samples were collected for pharmacokinetic evaluation. The pharmacokinetics of gavestinel were determined using compartmental analysis.
The mean clearance (CL) and central (Vc) and steady-state (Vss) volumes of distribution across the dose groups were 0.31-0.40 l x h(-1), 3.3-3.9 l, and 9.8-17 l, respectively. The mean terminal half-life ranged from 29 h to 56 h. Gavestinel was extensively bound to plasma protein (median percentage free |
---|---|
ISSN: | 0031-6970 1432-1041 |
DOI: | 10.1007/s002280050709 |